Silvant Capital Management LLC Novo Cure LTD Transaction History

Silvant Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$75.08 - $121.99 $17,118 - $27,813	-228 Reduced 6.02%	3,560 $267,000
Q2 2021 Aug 03, 2021	SELL	$130.4 - $225.58 $126,096 - $218,135	-967 Reduced 20.34%	3,788 $840,000
Q1 2021 May 11, 2021	SELL	$124.11 - $190.17 $96,929 - $148,522	-781 Reduced 14.11%	4,755 $629,000
Q4 2018 Feb 06, 2019	BUY	$28.72 - $52.63 $36,474 - $66,840	1,270 Added 29.77%	5,536 $185,000
Q3 2018 Nov 07, 2018	BUY	$32.0 - $52.4 $136,512 - $223,538	4,266 New	4,266 $224,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.88B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Silvant Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Silvant Capital Management LLC with notifications on news.